Payden & Rygel Investment Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Payden & Rygel Investment Group's AMGN Position: Q2 2024 in Review
Payden & Rygel Investment Group reduced its Amgen (AMGN) stake by 39% in Q2 2024, selling an estimated $6.67M and leaving 35,200 shares worth $11M. The position accounts for 0.89% of the portfolio, ranked #59.
Payden & Rygel Investment Group first reported a position in AMGN in Q3 2023 and has held it in 3 quarters since. The position peaked at $16.5M in Q1 2024. 2,784 funds tracked by Wall St. Rank hold AMGN as of Q2 2024.
- Payden & Rygel Investment Group held 35,200 shares of Amgen worth $11M as of Q2 2024.
- Payden & Rygel Investment Group sold 22,700 Amgen shares in Q2 2024, an estimated $6.67M.
- Amgen made up 0.89% of Payden & Rygel Investment Group's portfolio in Q2 2024, its #59 holding.
- Payden & Rygel Investment Group first reported a position in Amgen in Q3 2023 and has held it in 3 quarters since.
- Payden & Rygel Investment Group's Amgen position peaked at $16.5M in Q1 2024.
- 2,784 funds tracked by Wall St. Rank held Amgen as of Q2 2024.
Based on Payden & Rygel Investment Group's 13F filing for Q2 2024, filed 12 Aug 2024.